Fabry Disease, Cardiac Variant Clinical Trials
3 recruiting trials for Fabry Disease, Cardiac Variant. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06226987
Molecular Imaging in Fabry Disease of the Heart
Better methods for early detection of cardiac involvement in Fabry disease are needed to inform clinical management decisions that can help prevent or slow the progression of...
Sponsor: University of CambridgeEnrolling: 121 location
RECRUITINGNCT03362164
Evaluation of HEArt invoLvement in Patients With FABRY Disease
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Sponsor: Wuerzburg University HospitalEnrolling: 6501 location
RECRUITINGNCT06512571
CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study
Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by α-galactosidase A (GLA) gene mutations leading to reduced or undetectable α galactosidase A (α-Gal A)...
Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 3001 location